Expert Review of Clinical Pharmacology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 21. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - March 21, 2024 Category: Drugs & Pharmacology Authors: I Georgianos Panagiotis Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update
Expert Rev Clin Pharmacol. 2024 Mar 15:1-14. doi: 10.1080/17512433.2024.2330468. Online ahead of print.ABSTRACTINTRODUCTION: With newer anti-obesity medications (AOMs) being introduced at a rapid pace, it is prudent to make a concise and updated clinical practice document that may help busy clinicians in daily clinical practice. A group of metabolic physicians, diabetologists, endocrinologists, and bariatric surgeons assembled during the Integrated Diabetes and Endocrine Academy 2023 Congress (IDEACON, July 2023, Kolkata, India) to compile an update of pharmacotherapeutic options for managing people with obesity in India.A...
Source: Expert Review of Clinical Pharmacology - March 12, 2024 Category: Drugs & Pharmacology Authors: Subir Ray Nitin Kapoor Neeta Deshpande Sanjay Chatterjee Janardanan Kumar Om Tantia Ghanshyam Goyal Jagat Jyoti Mukherjee Awadhesh Kumar Singh Source Type: research

Anti-obesity medications: current and futureAn overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update
Expert Rev Clin Pharmacol. 2024 Mar 12. doi: 10.1080/17512433.2024.2330468. Online ahead of print.ABSTRACTINTRODUCTION: With newer anti-obesity medications (AOMs) being introduced at a rapid pace, it is prudent to make a concise and updated clinical practice document that may help busy clinicians in daily clinical practice. A group of metabolic physicians, diabetologists, endocrinologists, and bariatric surgeons assembled during the Integrated Diabetes and Endocrine Academy 2023 Congress (IDEACON, July 2023, Kolkata, India) to compile an update of pharmacotherapeutic options for managing people with obesity in India.AREAS ...
Source: Expert Review of Clinical Pharmacology - March 12, 2024 Category: Drugs & Pharmacology Authors: Subir Ray Nitin Kapoor Neeta Deshpande Sanjay Chatterjee Janardanan Kumar Om Tantia Ghanshyam Goyal Jagat Jyoti Mukherjee Awadhesh Kumar Singh Source Type: research

Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis
CONCLUSION: Exposure-efficacy relationships for IV and SC vedolizumab administration were comparable, confirming that both are equally effective during maintenance treatment.PMID:38441048 | DOI:10.1080/17512433.2024.2318465 (Source: Expert Review of Clinical Pharmacology)
Source: Expert Review of Clinical Pharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Geert D'Haens Maria Rosario Daniel Polhamus Nathanael L Dirks Chunlin Chen Krisztina Kisfalvi Christian Agboton S éverine Vermeire Brian G Feagan William J Sandborn Source Type: research